Oncology & Cancer

New test helps evaluate cancer drug's merit

(HealthDay) -- A new genetic test to help doctors determine if the drug Erbitux would be an effective treatment for certain colorectal cancer patients has been approved by the U.S. Food and Drug Administration.

Oncology & Cancer

Germ-line BRCA1/2 testing recommended in ovarian cancer

(HealthDay) -- Due to the potential survival and treatment response implications of BRCA mutation status, it is recommended that germ-line BRCA1/2 testing be offered to all women diagnosed with nonmucinous ovarian carcinoma, ...

Diseases, Conditions, Syndromes

Study finds early signs of malaria drug resistance in Africa

Africa's deadliest malaria parasite has shown resistance in lab tests to one of the most powerful drugs on the market -- a warning of possible resistance to follow in patients, scientists said Friday.

Genetics

Gene mapping for everyone? Study says not so fast

Gene scans for everyone? Not so fast. New research suggests that for the average person, decoding your own DNA may not turn out to be a really useful crystal ball for future health.

page 21 from 25